Purchases and Sales Made in Q3 2024 in T Scan Therapeutics, Inc. (TCRX)
This table provides information about the institutional ownership of T Scan Therapeutics, Inc. (TCRX) during Q3 2024. The information is specifically focused on institutions that hold shares of TScan Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 13, 2024
Q3 2024
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-585- 3.8% |
$2.91K - $4.38K
|
14.8K
$24.7K
|
|
Nov 08, 2024
Q3 2024
|
Tocqueville Asset Management L.P.
New York, NY |
SELL
|
- |
-4.1K- 1.95% |
$20.4K - $30.7K
|
206K
$344K
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-5.16K- 5.21% |
$25.6K - $38.6K
|
93.9K
$157K
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-6K- 7.5% |
$29.8K - $44.9K
|
74K
$124K
|
|
Nov 14, 2024
Q3 2024
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-10.8KClosed |
$53.6K - $80.8K
|
0
$0
|
|
Nov 06, 2024
Q3 2024
|
Cornercap Investment Counsel Inc
Atlanta, GA |
SELL
|
- |
-12.2K- 52.97% |
$60.4K - $91K
|
10.8K
$18K
|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-13.9K- 69.3% |
$69.2K - $104K
|
6.17K
$10.3K
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-23K- 21.33% |
$114K - $172K
|
84.7K
$141K
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-23.8K- 30.39% |
$118K - $178K
|
54.6K
$91.1K
|
|
Nov 14, 2024
Q3 2024
|
Troluce Capital Advisors LLC
Dorado, PR |
SELL
|
- |
-39.9K- 43.0% |
$198K - $299K
|
52.9K
$88.4K
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-54.9K- 33.58% |
$273K - $411K
|
109K
$181K
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-142K- 46.29% |
$707K - $1.07M
|
165K
$276K
|
|
Nov 12, 2024
Q3 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-482K- 96.4% |
$2.39M - $3.61M
|
18K
$30.1K
|
|
Nov 07, 2024
Q3 2024
|
Lmr Partners LLP
London, X0 |
SELL
|
- |
-594K- 89.21% |
$2.95M - $4.45M
|
71.8K
$120K
|